Korean Circ J.  2022 Oct;52(10):797-798. 10.4070/kcj.2022.0109.

Fulminant Myocarditis After SARSCoV-2 mRNA Vaccine Successfully Managed With Biventricular Impella Support: Multimodality Imaging Follow-Up

• Ching S
• Yue CS

• KMID: 2534045
• DOI: http://doi.org/10.4070/kcj.2022.0109

Figure

• 

  Figure 1 (A) Diffuse myocardial edema on T2-weighted CMR. (B) Diffuse non-ischemic pattern of late gadolinium enhancement on CMR. (C) Endomyocardial biopsy showed lymphocytic myocarditis. (D) Impella support with Impella RP in the right and Impella CP in the left ventricles respectively. (E) CMR at 6 months showed resolution of edema on T2 mapping. (F) Subepicardial LGE was evident on basal and mid-ventricular lateral walls. (G) Transthoracic echocardiogram at 6months showed normal left ventricular global longitudinal strain.CMR = cardiac magnetic resonance; LGE = late gadolinium enhancement.

Reference

1. Mevorach D, Anis E, Cedar N, et al. Myocarditis after BNT162b2 mRNA vaccine against Covid-19 in Israel. N Engl J Med. 2021; 385:2140–2149. PMID: 34614328.

2. Witberg G, Barda N, Hoss S, et al. Myocarditis after Covid-19 vaccination in a large health care organization. N Engl J Med. 2021; 385:2132–2139. PMID: 34614329.

3. Chua GT, Kwan MYW, Chui CSL, et al. Epidemiology of acute myocarditis/pericarditis in Hong Kong adolescents following Comirnaty vaccination. Clin Infect Dis. 2021; [Epub ahead of print].